Pfizer’s New Executive Committee Streamlines Upper Management
This article was originally published in The Pink Sheet Daily
Executive Summary
Global Pharmaceuticals President Katen, General Counsel Kindler and CFO Shedlarz will become vice chairmen. Katen will now have oversight of the company’s R&D, manufacturing and licensing activities. Shedlarz will lose CFO title but pick up responsibility for human resources.